Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Humana stock in Canada | $458.64

Own Humana shares in just a few minutes.

Humana Inc
+ $8.16 ( + 1.78%)

Humana is a healthcare plans business based in the US. Humana stocks (HUM.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $454.5 – a decrease of 0.47% over the previous week. Humana employs 48,700 staff and has a trailing 12-month revenue of around $80.5 billion.

How to buy shares in Humana

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HUM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Is it a good time to buy Humana stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

How has Coronavirus impacted Humana's stock price?

Since the stock market crash in March caused by coronavirus, Humana's stock price has had significant positive movement.

Its last market close was $458.64, which is 19.40% up on its pre-crash value of $369.67 and 120.24% up on the lowest point reached during the March crash when the stocks fell as low as $208.25.

If you had bought $1,000 worth of Humana stocks at the start of February 2020, those stocks would have been worth $643.29 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,375.92.

Humana stock price

Use our graph to track the performance of HUM stocks over time.

Humana shares at a glance

Information last updated 2021-10-23.
Latest market close$458.64
52-week range$368.38 - $473.85
50-day moving average $412.29
200-day moving average $429.97
Wall St. target price$486.46
PE ratio 24.4288
Dividend yield $2.65 (0.58%)
Earnings per share (TTM) $18.91

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Available Asset Types Stock Trading Fee Option Fee Account Fee ETF Transaction Cost Feature Table description
Wealthsimple Trade
Stocks, ETFs
Get 2 free stocks when you open a Wealthsimple Trade personal account and deposit and trade at least $150.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
Min. $1.00, Max. 0.5% of trade value
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95 - $6.95
$4.95 - $6.95 (+$1.25 per contract)
$0 if conditions met, otherwise $100/year
$4.95 - $6.95 is applicable for online stock, ETF and option trades only. Pay $4.95 when you qualify as an Active Trader (trade 150+ times per quarter).
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$9.95 + $1 per contract
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, otherwise $25/quarter
$0 - $8.75
Get up to 50 free trades. Be one of the first 100 new Qtrade clients to use the promo code 50FREETRADES and deposit a minimum of $10,000 (or top up to $15,000 to get $150 transfer fees waived). Valid until December 31, 2021.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.

Compare up to 4 providers

Online stock trading

Humana price performance over time

Historical closes compared with the close of $458.64 from 2021-10-27

1 week (2021-10-21) -0.47%
1 month (2021-09-28) 16.11%
3 months (2021-07-28) 4.04%
6 months (2021-04-28) 4.56%
1 year (2020-10-28) 10.98%
2 years (2019-10-28) 58.50%
3 years (2018-10-26) 44.11%
5 years (2016-10-28) 168.12%

Is Humana under- or over-valued?

Valuing Humana stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Humana's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Humana's P/E ratio

Humana's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Humana shares trade at around 24x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Humana's PEG ratio

Humana's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3537. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Humana's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Humana's EBITDA

Humana's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.2 billion.

The EBITDA is a measure of a Humana's overall financial performance and is widely used to measure a its profitability.

Humana financials

Revenue TTM $80.5 billion
Operating margin TTM 4.89%
Gross profit TTM $15.5 billion
Return on assets TTM 6.43%
Return on equity TTM 16.97%
Profit margin 3.09%
Book value $115.51
Market capitalisation $59.4 billion

TTM: trailing 12 months

Shorting Humana shares

There are currently 1.8 million Humana shares held short by investors – that's known as Humana's "short interest". This figure is 7.6% down from 1.9 million last month.

There are a few different ways that this level of interest in shorting Humana shares can be evaluated.

Humana's "short interest ratio" (SIR)

Humana's "short interest ratio" (SIR) is the quantity of Humana shares currently shorted divided by the average quantity of Humana shares traded daily (recently around 739972.08333333). Humana's SIR currently stands at 2.4. In other words for every 100,000 Humana shares traded daily on the market, roughly 2400 shares are currently held short.

However Humana's short interest can also be evaluated against the total number of Humana shares, or, against the total number of tradable Humana shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Humana's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Humana shares in existence, roughly 10 shares are currently held short) or 0.0138% of the tradable shares (for every 100,000 tradable Humana shares, roughly 14 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Humana.

Humana's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Humana.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Humana's total ESG risk score

Total ESG risk: 25.71

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Humana's overall score of 25.71 (as at 01/01/2019) is pretty good – landing it in it in the 33rd percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Humana is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Humana's environmental score

Environmental score: 2.6/100

Humana's environmental score of 2.6 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Humana is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Humana's social score

Social score: 18.54/100

Humana's social score of 18.54 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Humana is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Humana's governance score

Governance score: 5.07/100

Humana's governance score puts it squarely in the 3rd percentile of companies rated in the same sector. That could suggest that Humana is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Humana's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Humana scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Humana has, for the most part, managed to keep its nose clean.

Humana share dividends


Dividend payout ratio: 17.76% of net profits

Recently Humana has paid out, on average, around 17.76% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.61% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Humana shareholders could enjoy a 0.61% return on their shares, in the form of dividend payments. In Humana's case, that would currently equate to about $2.65 per share.

While Humana's payout ratio might seem low, this can signify that Humana is investing more in its future growth.

Humana's most recent dividend payout was on 29 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 29 September 2021 (the "ex-dividend date").

Have Humana's shares ever split?

Humana's shares were split on a 3:2 basis on 1 August 1991. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Humana shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Humana shares which in turn could have impacted Humana's share price.

Humana share price volatility

Over the last 12 months, Humana's shares have ranged in value from as little as $368.3751 up to $473.8507. A popular way to gauge a stock's volatility is its "beta".

HUM.US volatility(beta: 0.89)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Humana's is 0.8878. This would suggest that Humana's shares are less volatile than average (for this exchange).

Humana overview

Humana Inc. , together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site